Catalyst Wire Dossier Catalyst Wire Dossier

EGFR and COX-2 inhibitor (combination)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFR and COX-2 inhibitor (combination), covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor [Phase 1, Phase 2]

See pricing